"We’re in this with you, to help you get the care you need, safely. Vanderbilt Health has restarted surgeries, procedures and clinic visits that were paused or delayed. Safety is our top priority, with measures that follow – and in some cases exceed – local, state and CDC public health recommendations. Everyone wears a mask – patients, visitors, doctors, nurses and staff. We’re sanitizing rooms between each patient, and cleaning public spaces frequently throughout the day. We’re checking everyone for fever and symptoms before they enter our facilities. We’ve spaced chairs in waiting areas, limited the number who can ride elevators at once and made other changes so we can keep a safe (6 feet) physical distance."

During the past decade, Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC)" are "Avian Influenza" (3 trials), "H1N1 Influenza" (1 trials), "Influenza" (1 trials) and "Influenza Immunisation" (1 trials). Many other conditions were trialed in "Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC)" in a lesser frequency.

Most popular intervention types in "Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC)" are "Biological" (3 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "MF59" (2 trials), "A/H7N9" (1 trials), "AS03" (1 trials), "Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203" (1 trials) and "Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".